(Q38429861)

3 September 2017

1 reference

title

The kidney in obesity (English)

1 reference

3 September 2017

0 references

Josep Redon

1

1 reference

3 September 2017

Empar Lurbe

series ordinal

2

1 reference

3 September 2017

language of work or name

1 reference

1 June 2015

1 reference

Current Hypertension Reports

3 September 2017

published in

1 reference

3 September 2017

volume

17

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

555

1 reference

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

A prospective study of body mass index, weight change, and risk of stroke in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Atherosclerosis Risk in Communities Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Abdominal obesity is associated with increased risk of acute coronary events in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index and the risk of stroke in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Measures of obesity and cardiovascular risk among men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Gender difference in relationship between body mass index and development of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Estimated visceral adipose tissue, but not body mass index, is associated with reductions in glomerular filtration rate based on cystatin C in the early stages of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Waist to height ratio is an independent predictor for the incidence of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Metabolic syndrome and kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Relationship between chronic kidney disease and metabolic syndrome: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Risk factors for end-stage renal disease: 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Renal injury in the extremely obese patients with normal renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Inflammation and oxidative stress in obesity-related glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Kidney pathological changes in metabolic syndrome: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

New insights into epithelial-mesenchymal transition in kidney fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Podocyte injury damages other podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity in kidney disease: A heavyweight opponent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Combined renal effects of overweight and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

The effects of weight loss on renal function in patients with severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index and angiotensin-dependent control of the renal circulation in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Association of insulin resistance with chronic kidney disease in non-diabetic subjects with normal weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Chronic inflammation links cardiovascular, metabolic and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

21 January 2018

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Adiponectin promotes functional recovery after podocyte ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Visfatin is upregulated in type-2 diabetic rats and targets renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity, oxidative stress, and fibrosis in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Determination of early urinary renal injury markers in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Kidney function in severely obese adolescents undergoing bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Prevalence and factors related to urinary albumin excretion in obese youths.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Predictors of new-onset kidney disease in a community-based population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity and Risk for Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Influence of smoking and obesity on the development of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Metabolically healthy obesity and risk of incident CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Longitudinal relationships of metabolic syndrome and obesity with kidney function: Healthy Twin Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Obesity and mortality risk among younger dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Lycopene supplementation reduces TNF-α via RAGE in the kidney of obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Acetaminophen attenuates obesity-related renal injury through ER-mediated stress mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

The metabolic syndrome in hypertension: European society of hypertension position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Waist and hip circumferences and waist-hip ratio in 19 populations of the WHO MONICA Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-015-0555-Z

Body mass index and the risk of development of end-stage renal disease in a screened cohort

21 January 2018

1 reference

12 December 2020

Prognostic value of microalbuminuria during antihypertensive treatment in essential hypertension

1 reference

12 December 2020

Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy

1 reference

12 December 2020

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

1 reference

12 December 2020

The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death

1 reference

12 December 2020

Obesity, metabolic health, and the risk of end-stage renal disease

1 reference

12 December 2020

Association of metabolic syndrome with decreased glomerular filtration rate among 75,468 Chinese adults: a cross-sectional study

1 reference

12 December 2020

Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension

1 reference

12 December 2020

Effect of Obesity on the Outcome of Kidney Transplantation: A 20-Year Follow-Up

1 reference

12 December 2020

Adiposity patterns and the risk for ESRD in postmenopausal women

1 reference

12 December 2020

Lipid mediators of inflammation in obesity-related glomerulopathy

1 reference

12 December 2020

Association between metabolically unhealthy overweight/obesity and chronic kidney disease: the role of inflammation

1 reference

12 December 2020

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

1 reference

12 December 2020

Exercise-induced albuminuria is associated with perivascular renal sinus fat in individuals at increased risk of type 2 diabetes

1 reference

12 December 2020

Lifestyle factors, obesity and the risk of chronic kidney disease

1 reference

12 December 2020

The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study

1 reference

12 December 2020

10.1007/S11906-015-0555-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1017547125

0 references

1 reference